Literature DB >> 24927054

The use of hairpin DNA duplexes as HIV-1 fusion inhibitors: synthesis, characterization, and activity evaluation.

Liang Xu1, Xifeng Jiang1, Xiaoyu Xu1, Baohua Zheng2, Xueliang Chen2, Tao Zhang1, Fang Gao1, Lifeng Cai1, Maosheng Cheng3.   

Abstract

Discovery of new drugs for the treatment of AIDS that possess unique structures associated with novel mechanisms of action are of great importance due the rapidity with which drug-resistant HIV-1 strains evolve. Recently we reported on a novel class of DNA duplex-based HIV-1 fusion inhibitors modified with hydrophobic groups. The present study describes a new category of hairpin fusion inhibitor DNA duplexes bearing a 3 nucleotide loop located at either the hydrophobic or hydrophilic end. The new loop structures were designed to link 2 separate duplex-forming oligodeoxynucleotides (ODNs) to make helix-assembly easier and more thermally stable resulting in a more compact form of DNA duplex based HIV-1 fusion inhibitors. A series of new hairpin duplexes were tested for anti-HIV-1 cell-cell membrane fusion activity. In addition, Tm, CD, fluorescent resonance energy transfer assays, and molecular modeling analyses were carried out to define their structural activity relationships and possible mechanisms of action.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Fusion inhibitor; HIV-1; Hairpin DNA duplex; Loop domain

Mesh:

Substances:

Year:  2014        PMID: 24927054     DOI: 10.1016/j.ejmech.2014.05.068

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  2 in total

1.  DNA Triplex-Based Complexes Display Anti-HIV-1-Cell Fusion Activity.

Authors:  Liang Xu; Tao Zhang; Xiaoyu Xu; Huihui Chong; Wenqing Lai; Xifeng Jiang; Chao Wang; Yuxian He; Keliang Liu
Journal:  Nucleic Acid Ther       Date:  2015-08       Impact factor: 5.486

2.  Enfuvirtide-PEG conjugate: A potent HIV fusion inhibitor with improved pharmacokinetic properties.

Authors:  Shuihong Cheng; Yan Wang; Zhenxing Zhang; Xun Lv; George F Gao; Yiming Shao; Liying Ma; Xuebing Li
Journal:  Eur J Med Chem       Date:  2016-05-13       Impact factor: 6.514

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.